These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2201339)

  • 1. Levamisole as a therapeutic agent for colorectal carcinoma.
    Grem JL
    Cancer Cells; 1990 May; 2(5):131-7. PubMed ID: 2201339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracil.
    Grem JL
    Oncology (Williston Park); 1991 Mar; 5(3):63-70, 73; discussion 73-4. PubMed ID: 1829947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress of adjuvant chemotherapy in colon cancer].
    Toge T
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):554-9. PubMed ID: 8678512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
    Kodaira S; Shatari T; Nozawa K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial.
    Bandealy MT; Gonin R; Loehrer PJ; Monaco F; Einhorn LH
    Clin Cancer Res; 1998 Apr; 4(4):935-9. PubMed ID: 9563887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What's new in adjuvant therapy of colorectal cancers?].
    Louvet C
    Ann Chir; 1998; 52(6):487-90. PubMed ID: 9752495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in the treatment of colorectal cancer].
    Thuss-Patience PC; Reichardt P; Riess H; Kretzschmar A
    Med Klin (Munich); 2006 Feb; 101(2):114-9. PubMed ID: 16501908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in adjuvant and palliative chemotherapy of colorectal cancer: current status and perspectives].
    Scheithauer W
    Wien Klin Wochenschr; 1993; 105(20):568-79. PubMed ID: 7505075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical overview: adjuvant therapy of gastrointestinal cancer.
    Macdonald JS
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S4-11. PubMed ID: 15309508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant treatment of colonic carcinoma].
    Rochlitz CF; Herrmann R
    Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.
    Schippinger W; Jagoditsch M; Sorré C; Gnant M; Steger G; Hausmaninger H; Mlineritsch B; Schaberl-Moser R; Mischinger HJ; Hofbauer F; Holzberger P; Mittlböck M; Jakesz R;
    Br J Cancer; 2005 May; 92(9):1655-62. PubMed ID: 15856042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.